Asklepios BioPharmaceutical
Asklepios BioPharmaceutical, also known as AskBio, is a fully integrated gene therapy company dedicated to developing life-saving medicines for serious diseases. A subsidiary of Bayer AG, the company focuses on advancing genetic technology and AAV gene therapy, with a clinical pipeline targeting conditions such as muscular dystrophy, Parkinson's disease, and congestive heart failure.
Founded by Dr. Jude Samulski, AskBio has been at the forefront of genetic medicine since 1984, pioneering the use of viruses to target genetic diseases. The company emphasizes collaboration with patients, their families, and advocacy organizations to drive research and innovation in gene therapy.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.